SciClone (SCLN) Notes Possible Q1 Revenue Impact Due to NovaMed Accounting
Tweet Send to a Friend
SciClone Pharmaceuticals, Inc. (Nasdaq: SCLN) reported its expectations regarding financial results for the quarter ended March 31, 2013.
Friedhelm ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Friedhelm ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
